Entropy Technologies LP Has $2.28 Million Holdings in Corteva, Inc. $CTVA

Entropy Technologies LP decreased its stake in Corteva, Inc. (NYSE:CTVA) by 61.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,935 shares of the company’s stock after selling 53,939 shares during the quarter. Entropy Technologies LP’s holdings in Corteva were worth $2,275,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter worth about $25,000. Bank of Jackson Hole Trust acquired a new position in shares of Corteva in the 4th quarter worth approximately $28,000. Redmont Wealth Advisors LLC acquired a new position in shares of Corteva in the 3rd quarter worth approximately $29,000. Basepoint Wealth LLC bought a new stake in Corteva during the 4th quarter worth approximately $30,000. Finally, Jackson Grant Investment Advisers Inc. increased its holdings in Corteva by 90.6% during the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Down 0.6%

Shares of NYSE CTVA opened at $75.71 on Tuesday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The firm’s 50-day moving average is $80.19 and its 200-day moving average is $75.45. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $50.63 billion, a PE ratio of 44.53, a price-to-earnings-growth ratio of 2.33 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the previous year, the firm posted $1.13 earnings per share. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. Corteva’s payout ratio is presently 42.35%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on CTVA shares. Jefferies Financial Group lifted their price objective on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. BNP Paribas Exane raised their target price on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Argus upped their price target on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, March 31st. Oppenheimer increased their price objective on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Finally, Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $88.81.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.